Thursday, April 18, 2019 4:35:56 PM
flipper44,
Les's crescendo could be related to investigation, new trials, patents, improvements, partnerships and up to 6 year data with Direct Phase 1. I think sentiment_stocks could be right about the SAP having been the hold up but if the hold up was planned for then data could mostly be updated if unblinded supporting evidence for SAP changes is being used to validate the changes before being accepted for this trial. I think we all would like to see data sooner rather than later as it seems to be sufficient to prove this thersey works. I just wonder about comparisons based on what optimization means and how a longer timeline, within whatever pedal to the metal means, might make these differences clearer.
By the way, I just saw my misspellings and they were unintentional although I can see where you might think they were not. Somehow both got by me. I have been sending more messages without proofreading them lately just to get them out without being deleted from something I do with thw phone. Best wishes.
Les's crescendo could be related to investigation, new trials, patents, improvements, partnerships and up to 6 year data with Direct Phase 1. I think sentiment_stocks could be right about the SAP having been the hold up but if the hold up was planned for then data could mostly be updated if unblinded supporting evidence for SAP changes is being used to validate the changes before being accepted for this trial. I think we all would like to see data sooner rather than later as it seems to be sufficient to prove this thersey works. I just wonder about comparisons based on what optimization means and how a longer timeline, within whatever pedal to the metal means, might make these differences clearer.
By the way, I just saw my misspellings and they were unintentional although I can see where you might think they were not. Somehow both got by me. I have been sending more messages without proofreading them lately just to get them out without being deleted from something I do with thw phone. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
